Title:
RNAS FOR COMPLEMENT INHIBITION
Document Type and Number:
WIPO Patent Application WO/2023/129496
Kind Code:
A3
Abstract:
RNAs, such as miRNA and siRNA, and their use in treating complement-mediated disorders, are described.
Inventors:
GEGNER JASMIN (DE)
Application Number:
PCT/US2022/053920
Publication Date:
November 02, 2023
Filing Date:
December 23, 2022
Export Citation:
Assignee:
APELLIS PHARMACEUTICALS INC (US)
International Classes:
C12N15/113; A61K31/713; A61P7/00
Domestic Patent References:
| WO2021222549A1 | 2021-11-04 |
Foreign References:
| US20160222389A1 | 2016-08-04 | |||
| US20160369283A1 | 2016-12-22 | |||
| US20050255487A1 | 2005-11-17 |
Attorney, Agent or Firm:
DAUKSS, Dana M. et al. (US)
Download PDF: